Clinical Study
Biological Markers and Response to Neoadjuvant Taxane-Based Chemotherapy in Patients with Locally Advanced Breast Cancer
Table 1
Patients' characteristics.
| Variable | Baseline characteristics of all patients (n = 95) | Number | % |
| Age at diagnosis | | | <50 years | 57 | 60 | ≥50 years | 38 | 40 | Clinical tumor size | | | <5 cm | 9 | 9.5 | ≥5 cm | 86 | 90.5 | Lymph node status | | | N0 | 19 | 20 | N1 | 55 | 55.6 | N2 | 21 | 22.1 | Histologic grade | | | grade II | 65 | 68.4 | grade III | 30 | 31.6 | HmR Status | | | HmR positive | 74 | 77.9 | HmR negative | 21 | 22.1 | Her2/neu status | | | Her2/neu+ | 20 | 21.1 | Her2/neu− | 75 | 78.9 | P53 status | | | Inactive p53 | 29 | 31.5 | Intact p53 | 66 | 69.5 |
| Total | 95 | 100 |
|
|